accreditation and certification

intended audience

This activity was developed for physicians, nurse practitioners, nurses, and other health care providers treating patients with Type 2 diabetes.

statement of need

For patients with diabetes or hyperglycemia, any hospitalization can present countless hazards. There are concerns about how health care clinicians can best care for the patient entering the hospital, particularly in an emergency situation. There are questions about how health care professionals optimally manage blood glucose levels in patients whose scheduling and diet are disrupted. Hospital staff also face difficulty in transitioning inpatients with diabetes and hyperglycemia to outpatient management. Potentially compounding these issues is the level of communication among the various physicians, nurses, and other health care providers who have a say in the patient's care. This activity will address the issues arising at patient transitions to assist in optimizing the patient's long-term care and well-being.

 

learning objectives

Upon completion of this activity, participants should be better able to:

Describe the growing problem of diabetes and hyperglycemia and their impact on patients
entering the hospital
Outline assessment strategies and initial inpatient glycemic management for the newly
hospitalized patient
Discuss the use of insulin and nutritional support for patients with diabetes and hyperglycemia
within the hospital to ensure safe transitions from criticalcare to other inpatient settings
Determine educational and discharge needs of patients and their families as well as improve
communication with outpatient care providers

accreditation and certification

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Annenberg Center designates this educational activity for a maximum of 3.5 AMA PRA Category 1 Credits tm. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Annenberg Center for Health Sciences is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners. Provider # 040207. The Annenberg Center designates this program for 3.5 contact hours of continuing education.

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
A maximum of 3.5 contact hours may be earned for successful completion of this activity.

There is no charge for this activity. Statements of Credit will be provided by mail following activity participation, and upon completion and return of the evaluation form to the Annenberg Center for Health Sciences. Please allow 4-6 weeks for the delivery of your statement.

disclosure

It is the policy of the Annenberg Center to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any significant relationship with those supporting the activity or any others whose products or services are discussed.

In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center policy, the following disclosures have been made:

Wayman Wendell Cheatham, MD Research Support Amylin Pharmaceuticals
Biodel, Inc.
DiObex
Merck & Co., Inc.
Novo Nordisk Pharmaceuticals, Inc.
Pfizer Inc.
Roche
Takeda Pharmaceuticals
Consultant Biodel, Inc.
DiObex
ONO Pharmaceuticals
Takeda Pharmaceuticals, Inc.
Speakers Bureau Merck & Co., Inc.
 
Belinda Childs, ARNP, MN, CDE Research Support Amylin Pharmaceuticals
Biodel, Inc.
Medtronic
Roche
Consultant Amylin Pharmaceuticals
Novo Nordisk Pharmaceuticals, Inc.
Roche
Speakers Bureau Amylin Pharmaceuticals
Novo Nordisk Pharmaceuticals, Inc.
 
Davida F. Kruger, MSN, APRN-BC, BC-ADM Research Support Amylin Pharmaceuticals
Eli Lilly and Company
National Institutes of Health (NIH)
Employee National Institutes of Health (NIH)
Consultant Abbott Laboratories
Agametrics
Amylin Pharmaceuticals
Animas Corporation
Council for the Advancement of Diabetes Research and Education (CADRE)
Eli Lilly and Company
Home Diagnostics, Inc.
Novo Nordisk Pharmaceuticals, Inc.
Patton Medical Devices
Seattle Medical
Speakers Bureau Abbott Laboratories
Agametrics
Amylin Pharmaceuticals
Animas Corporation
Council for the Advancement of Diabetes Research and Education (CADRE)
Eli Lilly and Company
Home Diagnostics, Inc.
Novo Nordisk Pharmaceuticals, Inc.
Seattle Medical
sanofi-aventis
Takeda Pharmaceuticals, Inc.
Share Holder Amylin Pharmaceuticals
Dexcom
Patton Medical Devices
 
Richard Rubin, PhD Research Support Amylin Pharmaceuticals
Animas Corporation
Eli Lilly and Company
Lifescan, Inc.
Medinfo
Medtronic
Novo Nordisk Pharmaceuticals, Inc.
sanofi-aventis
Valeritas
Consultant Amylin Pharmaceuticals
Animas Corporation
Eli Lilly and Company
Lifescan, Inc.
Medinfo
Medtronic
Novo Nordisk Pharmaceuticals, Inc.
sanofi-aventis
Valeritas
 
Anne Greenberg (medical writer) No interests or relationships to report

The following faculty have no significant relationship to disclose:

Gregory A. Maynard, MD

All staff at the Annenberg Center for Health Sciences at Eisenhower have nothing to disclose.

The following faculty for this activity have disclosed that there will be discussion about the use of products for non-FDA approved indications:

Davida F. Kruger, MSN, APRN-BC, BC-ADM

The following faculty for this activity have disclosed that there will be no discussion about the use of products for non-FDA approved applications:

Wayman Wendell Cheatham, MD
Belinda Childs, ARNP, MN, CDE
Gregory A. Maynard, MD
Richard Rubin, MD

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage the practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient's unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

If you need reasonable, special accommodations or have questions about any of our activities, please contact Charles Woller by phone at 800-321-3690 by fax at 760-773-4550, or by .

This activity is supported by an independent educational grant from Takeda Pharmaceuticals North America, Inc.

This activity is an enduring material and consists of a website. Successful completion is achieved by reading and/or viewing the material, reflecting on its implications in your practice, and completing the assessment component.

The estimated time to complete the activity is 3.5 hours.

If you participated in the DVD version of this activity, you may not obtain CE credit for participation in this Web-based version.

This activity was originally released in July 2008 and is eligible for credit through June 2009.

 

 

Copyright 2008
Annenberg Center for Health Sciences
at Eisenhower